Live Analyst Rating Changes 24314 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/David Larsen
BTIG

David Larsen

BTIG
Wall Street Analyst
★★★★☆
#827
on 13Foresight · ranked by our own returns
59%
Success Rate
+16.7%
Average Return
39 of 66 calls profitable · +11.6% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 59% of David Larsen's ratings turned a profit when each position was held for 1 year — averaging +16.7% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

83 Buy 33 Hold 0 Sell
David's Stock Coverage 35 ratings · 2026-08-13
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
HIMS
Hims & Hers Health
 Aug 11, 2026 HOLD Buy
-6.4% avg upside
22 analysts
 — -5.7% ·
OMDA
Omada Health, Inc.
 Aug 10, 2026 BUY Strong Buy
+9.8% avg upside
12 analysts
$35.00
46.09% Upside
 -2.5% ·
CCSI
Consensus Cloud Solutions
 Aug 10, 2026 BUY Hold
-13.8% avg upside
6 analysts
$50.00
34.88% Upside
 +2.2% ·
ASTH
Astrana Health
 Aug 09, 2026 BUY Strong Buy
+64.7% avg upside
16 analysts
$65.00
84.66% Upside
 -7.4% ·
PRVA
Privia Health Group
 Aug 09, 2026 BUY Strong Buy
+47.3% avg upside
26 analysts
$35.00
62.47% Upside
 -2.4% ·
CYRX
CryoPort
 Aug 07, 2026 BUY Strong Buy
+9.8% avg upside
15 analysts
$25.00
69.12% Upside
 +0.3% ·
LFST
Lifestance Health Group
 Aug 07, 2026 BUY Strong Buy
-5.5% avg upside
15 analysts
$16.00
33.25% Upside
 +12.4% ·
LFMD
LifeMD
 Aug 06, 2026 BUY Strong Buy
+210.3% avg upside
14 analysts
$9.00
174.84% Upside
 -0.6% ·
AMWL
American Well
 Aug 05, 2026 HOLD Buy
+12.2% avg upside
15 analysts
 — -2.8% ·
MDLN
Medline
 Aug 05, 2026 BUY Strong Buy
+32.3% avg upside
27 analysts
$55.00
56.32% Upside
 -3.0% ·
HSIC
Henry Schein
 Aug 04, 2026 BUY Buy
+0.1% avg upside
25 analysts
$100.00
10.88% Upside
 +0.1% ·
BTSG
BrightSpring Health Services, Inc.
 Aug 03, 2026 BUY Strong Buy
+10.3% avg upside
20 analysts
$90.00
49.79% Upside
 +0.4% ·
TDOC
Teladoc
 Jul 29, 2026 HOLD Buy
+330.2% avg upside
38 analysts
 — -24.2% ·
PGNY
Progyny
 Jul 24, 2026 BUY Strong Buy
+28.2% avg upside
14 analysts
$40.00
55.87% Upside
 -17.0% ·
HQY
Healthequity
 Jul 24, 2026 BUY Strong Buy
+7.9% avg upside
20 analysts
$115.00
9.08% Upside
 +11.7% ·
EVH
Evolent Health
 Jul 16, 2026 BUY Strong Buy
+130.3% avg upside
19 analysts
$8.00
85.23% Upside
 -25.6% ·
STLN
Starling Oncology Institute
 Jul 15, 2026 BUY Strong Buy
+12.8% avg upside
7 analysts
$9.00
45.60% Upside
 +11.7% ·
SLP
Simulations Plus
 Jun 16, 2026 HOLD Buy
+106.8% avg upside
11 analysts
$18.50
0.96% Upside
 +0.4% ·
VEEV
Veeva Systems
 Jun 03, 2026 BUY Buy
+0.0% avg upside
37 analysts
$340.00
43.40% Upside
 +41.4% ·
DOCS
Doximity
 May 14, 2026 HOLD Buy
+37.3% avg upside
28 analysts
 — +38.8% ·
DCGO
DocGo
 May 12, 2026 HOLD Buy
+318.8% avg upside
7 analysts
 — +9.8% ·
HCAT
Health Catalyst
 May 12, 2026 HOLD Buy
+213.2% avg upside
15 analysts
 — +20.3% ·
DH
Definitive Healthcare Corp
 May 11, 2026 HOLD Hold
+709.9% avg upside
19 analysts
 — -29.2% ·
OMCL
Omnicell
 Apr 28, 2026 HOLD Strong Buy
+32.0% avg upside
12 analysts
 — -18.2% ·
IQV
IQVIA Holdings
 Feb 05, 2026 HOLD Strong Buy
+1.4% avg upside
39 analysts
 — +33.5% ·
PIII
P3 Health Partners
 Nov 14, 2025 HOLD Buy
+1957.4% avg upside
8 analysts
 — +69.3% ·
AGL
Agilon Health
 Nov 04, 2025 HOLD Buy
-23.2% avg upside
26 analysts
 — +434.7% ·
BBLNF
Babylon Holdings
 Jun 23, 2023 HOLD Buy
+65549900.0% avg upside
6 analysts
 — · ·
CRL
Charles River Labs
 Aug 14, 2019 HOLD Strong Buy
-17.2% avg upside
35 analysts
 — +69.5% ·
CVS
CVS Health
 Aug 14, 2019 HOLD Strong Buy
+12.0% avg upside
39 analysts
 — +15.6% ·
COR
Cencora
 Aug 14, 2019 HOLD Buy
+2.2% avg upside
44 analysts
 — +30.1% ·
CAH
Cardinal Health
 Nov 16, 2018 HOLD Strong Buy
-13.5% avg upside
29 analysts
$55.00
76.77% Downside
 +5.7% ·
ACH
Accendra Health
 Oct 31, 2018 HOLD Sell
+1297.6% avg upside
17 analysts
$9.00
625.78% Upside
 -13.7% ·
MCK
McKesson
 May 29, 2018 HOLD Strong Buy
-13.2% avg upside
28 analysts
$160.00
81.97% Downside
 -10.2% ·
MDRX
Veradigm
 Jun 19, 2017 HOLD Buy
+197.2% avg upside
22 analysts
$13.00
157.49% Upside
 +2.7% ·
🔒 30 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
David Larsen — Frequently Asked Questions
How accurate are David Larsen's stock ratings?
Based on the calls 13Foresight could measure, about 51% of David's ratings were profitable over a one-year hold, with an average return of +15.9% per rating, or +10.9% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is David ranked on 13Foresight?
David Larsen is currently ranked #827 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does David cover?
David most recently has ratings on HIMS, OMDA, CCSI, ASTH, PRVA, CYRX, LFST, LFMD, AMWL, MDLN, HSIC, BTSG and 23 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.